Business Context and Reporting Period
This Form 8-K was filed by GBS Inc. (trading symbol: GBS) on September 9, 2022. The registrant is an emerging growth company incorporated in Delaware. The report details the execution of new employment agreements with two senior executives through its subsidiary, Glucose Biosensor Systems (Greater China) Pty Ltd.
Key Financial Metrics
This filing does not contain revenue, profit, cash flow, margin, debt, or liquidity metrics. The document focuses exclusively on executive compensation arrangements.
Material Changes
The primary material change reported is the amendment and superseding of prior employment agreements for two key officers effective September 9, 2022:
- Spiro Sakiris (Chief Financial Officer): New agreement replaces the April 30, 2019 contract.
- Harry Simeonidis (President Asia Pacific, Sales and Marketing): New agreement replaces the June 17, 2019 contract.
Management Commentary and Compensation Details
The filing outlines specific compensatory arrangements for the named executives:
- Base Salary: Mr. Sakiris receives $248,004 annually; Mr. Simeonidis receives $282,449 annually.
- Bonus Structure: Both executives are eligible for an annual bonus of up to 20% of their gross base salary. 50% is tied to Company objectives, and the remainder to individual objectives.
- Retirement Contributions: Mandatory Australian superannuation contributions at 10.5%, subject to a cap of $18,944 per annum.
- Automobile Allowance: Mr. Sakiris receives $13,778 annually; Mr. Simeonidis receives $16,534 annually.
- Termination Terms: Employment is terminable on six months' notice by either party, or immediately without notice for serious misconduct, negligence, or criminal conviction.
- Restrictive Covenants: Agreements include non-compete clauses effective during employment and for up to six months post-employment within specified regions, as well as restrictions on soliciting employees or clients.
Investor Verification Checklist
- Verify the total annual cash compensation impact of the new agreements ($530,453 in combined base salaries).
- Review the full text of Exhibits 10.1 and 10.2 for complete terms regarding intellectual property and non-compete geographic definitions.
- Confirm the company's cash position to ensure it can sustain the increased executive compensation obligations.
- Check for any subsequent filings regarding the performance metrics used to calculate the variable bonus components.